Phase 3 data on retatrutide (triple GLP-1/GIP/glucagon agonist) showing nearly 29% weight loss, the pending approval of CagriSema (GLP-1/amylin combination), and the arrival of oral non-peptide GLP-1 agonists like orforglipron all suggest we are at the start of a metabolic therapeutics renaissance
LiPo Charging Youll need a LiPo-specific charger to charge up your LiPo batteries
Thankfully, Felix makes requesting online semaglutide prescriptions a seamless process
The Verdict: Not a reliable GLP-1 booster
While their clinical standards are high, they have faced criticism on Trustpilot (3.4 rating) regarding billing and scheduling hiccups
Cigna, for one, expects the slowdown to continue for the remainder of the year, chief financial officer Ann Dennison said